These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 8046266)
1. Progress in the chemotherapy of leprosy. Grosset JH Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266 [No Abstract] [Full Text] [Related]
2. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs. Almeida JG Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367 [No Abstract] [Full Text] [Related]
3. Does dapsone resistance really matter in the MDT era? Ji B Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322 [No Abstract] [Full Text] [Related]
4. Search for effective short-course regimens for the treatment of leprosy. Pattyn SR Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183 [No Abstract] [Full Text] [Related]
5. The chemotherapy of leprosy. Part 2. Ellard GA Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319 [No Abstract] [Full Text] [Related]
6. Dormancy, drug resistance or dependency; some thoughts to ponder. Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116 [No Abstract] [Full Text] [Related]
7. Prospects for chemotherapy of leprosy. Ji B Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659 [No Abstract] [Full Text] [Related]
8. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance. Waters MF; Pearson JM; Rees RJ Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850 [No Abstract] [Full Text] [Related]
9. Drug resistance in leprosy: lessons from past and future perspective. Gupta UD; Katoch VM Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973 [TBL] [Abstract][Full Text] [Related]
10. Multi-drug therapy in leprosy. Girdhar BK Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084 [No Abstract] [Full Text] [Related]
11. [Drug resistance of Mycobacterium leprae]. Pattyn SR Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466 [No Abstract] [Full Text] [Related]
12. Multidrug resistant Mycobacterium leprae from patients with leprosy. Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358 [TBL] [Abstract][Full Text] [Related]
13. Drug-resistant leprosy: monitoring and current status. Williams DL; Gillis TP Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028 [No Abstract] [Full Text] [Related]
14. Dapsone drug resistance in the MDT era. Roche PW; Neupane KD; Failbus SS; Butlin CR Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related]
15. Concepts behind the development of multiple drug therapy regimens in leprosy. Waters MF Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437 [No Abstract] [Full Text] [Related]
16. Effect of mono treatment and combined treatment on the morphology of Myco. lepare in the skin. Leiker DL Lepr Rev; 1975 Jun; 46(2 Suppl):73-9. PubMed ID: 1100967 [No Abstract] [Full Text] [Related]
17. Detection of drug-resistant Mycobacterium leprae using molecular methods. Williams DL; Gillis TP Indian J Lepr; 1999; 71(1):137-53. PubMed ID: 10439334 [No Abstract] [Full Text] [Related]
18. Committee 4: workshop on experimental chemotherapy of leprosy. Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876 [No Abstract] [Full Text] [Related]
19. Drug resistance and multi-drug therapy in leprosy. Chatterjee BR Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576 [No Abstract] [Full Text] [Related]
20. Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser; 1982; 675():1-33. PubMed ID: 6806990 [No Abstract] [Full Text] [Related] [Next] [New Search]